PolyPid Ltd. (PYPD)
PYPD Stock Price Chart
Explore PolyPid Ltd. interactive price chart. Choose custom timeframes to analyze PYPD price movements and trends.
PYPD Company Profile
Discover essential business fundamentals and corporate details for PolyPid Ltd. (PYPD) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
26 Jun 2020
Employees
57.00
Website
https://www.polypid.comCEO
Dikla Czaczkes Akselbrad
Description
PolyPid Ltd. is an advanced-stage biopharmaceutical company specializing in the development, manufacturing, and commercialization of therapeutic solutions. These solutions are based on its proprietary polymer-lipid encapsulation matrix (PLEX) platform, with the goal of addressing significant unmet medical needs. The company's leading product candidate, D-PLEX100, is currently undergoing Phase III clinical trials. It is being evaluated for its efficacy in preventing surgical site infections (SSIs) following both sternal (bone) and abdominal (soft tissue) procedures. Established in 2008, PolyPid Ltd. is headquartered in Petah Tikva, Israel.
PYPD Financial Timeline
Browse a chronological timeline of PolyPid Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 Aug 2026
EPS estimate is -$0.32, while revenue estimate is $300.00k.
Earnings released on 13 May 2026
EPS came in at -$0.35 surpassing the estimated -$0.47 by +25.53%.
Earnings released on 11 Feb 2026
EPS came in at -$0.41 falling short of the estimated -$0.34 by -20.59%.
Earnings released on 12 Nov 2025
EPS came in at -$0.37 surpassing the estimated -$0.54 by +31.48%.
Earnings released on 13 Aug 2025
EPS came in at -$0.78 falling short of the estimated -$0.53 by -47.17%.
Earnings released on 14 May 2025
EPS came in at -$0.70 surpassing the estimated -$0.80 by +12.50%.
Earnings released on 12 Feb 2025
EPS came in at -$1.13 falling short of the estimated -$0.90 by -25.56%.
Earnings released on 13 Nov 2024
EPS came in at -$1.22 falling short of the estimated -$1.07 by -14.02%.
Earnings released on 14 Aug 2024
EPS came in at -$1.25 surpassing the estimated -$1.51 by +17.22%.
Earnings released on 8 May 2024
EPS came in at -$1.37 surpassing the estimated -$1.96 by +30.10%.
Earnings released on 14 Feb 2024
EPS came in at -$3.97 falling short of the estimated -$2.17 by -82.95%.
Earnings released on 8 Nov 2023
EPS came in at -$3.40 surpassing the estimated -$3.62 by +6.08%.
Stock split effective on 21 Sept 2023
Shares were split 1 : 30 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 9 Aug 2023
EPS came in at -$3.90 falling short of the estimated -$0.31 by -1.16k%.
Earnings released on 10 May 2023
EPS came in at -$8.41 falling short of the estimated -$0.26 by -3.13k%.
Earnings released on 8 Feb 2023
EPS came in at -$9.61 surpassing the estimated -$10.51 by +8.56%.
Earnings released on 9 Nov 2022
EPS came in at -$14.41 surpassing the estimated -$15.62 by +7.75%.
Earnings released on 10 Aug 2022
EPS came in at -$18.32 surpassing the estimated -$20.72 by +11.58%.
Earnings released on 11 May 2022
EPS came in at -$18.92 surpassing the estimated -$20.42 by +7.35%.
Earnings released on 9 Feb 2022
EPS came in at -$21.32 falling short of the estimated -$15.62 by -36.49%.
Earnings released on 10 Nov 2021
EPS came in at -$15.92 surpassing the estimated -$19.82 by +19.68%.
Earnings released on 11 Aug 2021
EPS came in at -$16.82 surpassing the estimated -$17.42 by +3.44%.
PYPD Stock Performance
Access detailed PYPD performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
